Do a web search for the term “electroceuticals,” and many of the results tout a form of alternative medicine. GlaxoSmithKline PLC is angling to make the term a lot more mainstream.
A new funding initiative from the drug giant aims to back academic scientists who are trying to answer early questions about the possibility of using extremely focused electrical impulses to...